A drug maker has stepped in to offer a $1 pill alternative to the pricey $750 anti-parasite treatment that sparked public outrage last month.
Imprimis Pharmaceuticals said Thursday that it would make a formulation that is similar to Daraprim, whose price Turing Pharmaceuticals jacked up almost overnight from $13.50 to $750 a pill.
The 5,000-percent price hike started a wave of public attacks on the small drug maker's 32-year-old CEO Martin Shkreli. Democratic presidential candidate Hillary Clinton repeatedly accused Shkreli of price gouging, and her competitor Bernie Sanders refused a donation from the former hedge fund manager.
Now Imprimis is stepping in to offer what it calls a cheaper alternative to Daraprim. It would start offering the formulation as low as $99 for a 100-count bottle, the company said Thursday.